Contact
925 Chestnut Street
Suite 110
Philadelphia, PA 19107
Available Therapeutic Technologies
| Case Number | Title Non-Confidential Summary |
Issued Patent | Lead Inventor's Info |
| BER_ERI.001 | Use of Tempol in the Prevention of Photoaging | US Patent No. 5,840,734 | |
| BRA_PAU.001 | Novel drug to inhibit human platelet aggregation NCS for BRA_PAU.001 |
||
| CRO_CAR.002 | Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene NCS for Croce tumor suppressor techs (CRO_CAR.002, 004, 005, 016) |
US Patent No. 7,141,417 US Patent No. 7,777,005 |
|
| CRO_CAR.004 | The Human FHIT Gene NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
US Patent No. 7,220,834 US Patent No. 6,774,217 US Patent No. 6,242,212 US Patent No. 5,928,884 |
|
| CRO_CAR.009 | TCL-1 Gene And Protein And Related Methods And Compositions NCS for Croce TCL-1 techs (CRO_CAR.009, 015) |
US Patent No. 5,985,598 US Patent No. 7,175,995 US Patent No. 7,749,715 |
|
| CRO_CAR.015 | Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression NCS for Croce TCL-1 techs (CRO_CAR.009,015) |
US Patent No. 7,728,189 US Patent No. 8,168,854 |
|
| CRO_CAR.016 | Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
||
| CRO_CAR.017 | Role of microRNA Genes In Human Cancer NCS for Croce miRNA techs (CRO 17, 25) |
US Patent No. 7,723,035 US Patent App 12/319,331 US Patent App 12/727,778 |
|
| CRO_CAR.019 | Involvement Of The ALL-1 Gene In A Solid Tumor1 | US Patent No. 5,567,586 | |
| CRO_CAR.025 | microRNA genes in cancer diagnosis and treatment NCS for Croce miRNA techs (CRO 17, 25) |
US Patent N.o 7,723,030 US Patent App 12/751,463 US Patent App 12/767,279 |
|
| DIE_BER.010 | Recombinant Rabies for Pre- and Post-Exposure Prophylaxis | Link | |
| DIE_BER.012 | A Method to Modulate and Enhance the Immune Response through Prime/Boost Immunization NCS for DIE_BER.012 |
Link | |
| DIE_BER.013 | Rabies TriGAS in a combination vaccine NCS for DIE_BER.013 |
||
| DUR_MAT.005 | Insulin And Insulin-Associated Peptides For Cerebral Health NCS for DUR_MAT.005 |
||
| FER_AND.002 | Antibody-based Inhibitors of Excessive Deposition of Fibrotic Tissue NCS for FER_AND.002 |
Link | |
| HOU_YAM.005 | Apoptosis of Cardiomyocytes | Link | |
| IOZ_REN.001 | A Role For Decorin In Tumor Suppression | US Patent No. 6,524,573 | Link |
| KAS_DAV.001 | A Small Bowel Purgative for Wireless Capsule Endoscopy NCS for KAS_DAV.001 |
||
| KOP_HIL.006 | Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins | US Patent No. 6,042,832 US Patent No. 6,448,070 |
|
| MEN_SUE.002 | Cell Migration Leading to Posterior Capsule Opacification can be Prevented by Inhibition of Src Kinase Activities NCS for MEN_SUE.002 |
US Patent Appl. 11/913,798 | |
| NEV_MAR.005/ NJA_VIN.002/ NJA_VIN.005 | Treatment of Prostate Cancer NCS for NEV_MAR.005, NJA_VIN.002, NJA_VIN.005 |
||
| RAB_JOS.001 | Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression NCS for RAB_JOS.001 |
||
| SAN_JAM.001 | Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces NCS for SAN_JAM.001, .002 |
US Patent No. 6,855,801 | |
| SAN_JAM.002 | Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery NCS for SAN_JAM.001, .002 |
US Patent No. 7,259,140 | |
| SCH_JAY.001 | Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology NCS for SCH_JAY.001, 002, 004, 008 |
Link | |
| SCH_JAY.002 | Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease NCS for SCH_JAY.001, 002, 004, 008 |
Link | |
| SCH_JAY.004 | Method of Treating Parkinson's Disease and Composition for the Same NCS for SCH_JAY.001, 002, 004, 008 |
US Patent No. 7,160,913 | Link |
| SCH_JAY.008 | Treatment of Parkinson's Disease and Parkinson's Disease Treatment-related Complications with RNA Inhibition Therapies NCS for SCH_JAY.001, 002, 004, 008 |
Link | |
| SHO_SUN.001 | Pure Protein Nanoparticles for Drug Delivery NCS for SHO_SUN.001 |
||
| STR_DAV.001 | SV40 Viral Vectors for Targeted Integration Into Cells | US Patent No. 5,863,794 | Link |
| SUN_XIA.001 | Implantable Sensor and System for Measurement and Control of Blood Constituent Levels | US Patent No. 5,995,860 US Patent No. 6,122,536 |
|
| THO_JEF.001 | Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal | US Patent No. 6,358,536 | |
| TRO_DAV.001 | Increase bioavailability and efficacy of ALS-treating pharmacological compounds NCS for TRO_DAV.001 |
||
| WAL_PAU.010 | Microwave Balloon Catheter NCS for WAL_PAU.010 |
||
| WIC_ERI.010 | Competitive Inhibition of miRNAs NCS for WIC_ERI.010 |
||
| WIL_JOH.005 | Design and Development of Masked Therapeutic Antibodies to Limit Off-Target Effects: Application to Anti-EGFR Antibodies (Also known as "EGFR-Specific ScFvs Engineered to Enable Selective Antigen Recognition Upon Proteolytic Activation") | ||
| ZAL_AND.002 | Inhibition of Extracellular Matrix Synthesis By Antisense Compounds Directed to Nuclear Proto-Oncogenes | US Patent No. 6,133,242 |